Table 2 Resistance profile of diarrheagenic Escherichia coli isolates grouped by different populations
Antimicrobial Agent | Population groups (Resistance %) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
< 1 year | 1–4 years | 5–14 years | 15–24 years | 25–64 years | > 65 years | |||||||
male | female | male | female | male | female | male | female | male | female | male | female | |
Ampicillin | 73.2 | 74.4 | 71.6 | 69.7 | 69.1 | 66.4 | 67.6 | 64.6 | 67.1 | 67.1 | 68.1 | 69.4 |
Ampicillin/sulbactam | 29.4 | 25.3 | 24.7 | 24.4 | 25.6 | 24.4 | 22.8 | 22.4 | 22.1 | 20.9 | 25.3 | 19.3 |
Cefazolin | 51.6 | 48.7 | 43.1 | 43.9 | 42.1 | 35.6 | 38.9 | 39.2 | 38.2 | 37.2 | 37.3 | 36.0 |
Cefotaxime | 34.7 | 33.3 | 32.8 | 31.2 | 26.8 | 28.2 | 29.5 | 29.4 | 25.6 | 24.4 | 26.3 | 22.8 |
Cefoxitin | 11.8 | 15.4 | 10.3 | 8.7 | 8.1 | 8.9 | 6.8 | 9.7 | 7.1 | 6.8 | 8.5 | 7.2 |
Ceftazidime | 9.5 | 10.3 | 9.2 | 10.8 | 6.8 | 8.2 | 6.2 | 6.7 | 4.5 | 5.5 | 5.3 | 4.9 |
Chloramphenicol | 19.7 | 19.2 | 21.5 | 22.6 | 20.8 | 25.2 | 16.8 | 18.1 | 14.4 | 13.6 | 16.5 | 15.4 |
Ciprofloxacin | 16.7 | 26.9 | 24.4 | 18.7 | 22.5 | 17.0 | 20.5 | 21.8 | 20.9 | 19.4 | 27.5 | 23.3 |
Gentamicin | 31.2 | 25.6 | 30.2 | 28.3 | 22.0 | 24.4 | 21.6 | 19.7 | 18.1 | 18.6 | 19.0 | 18.1 |
Imipenem | 1.8 | 2.9 | 2.0 | 0.2 | 1.3 | 0.0 | 3.0 | 2.3 | 1.5 | 1.3 | 2.8 | 1.3 |
Nalidixic acid | 57.5 | 55.8 | 55.5 | 53.6 | 59.2 | 52.6 | 57.8 | 61.5 | 58.1 | 57.9 | 66.4 | 52.4 |
Tetracycline | 59.8 | 55.8 | 64.4 | 60.2 | 57.2 | 62.2 | 54.4 | 54.0 | 49.2 | 47.6 | 49.3 | 46.6 |
Trimethoprim-sulfamethoxazole | 47.2 | 55.4 | 48.1 | 51.2 | 46.1 | 51.1 | 43.2 | 45.2 | 41.2 | 37.4 | 42.7 | 42.1 |
Colistin E | 7.4 | 13.3 | 6.3 | 5.1 | 5.0 | 3.2 | 9.8 | 5.8 | 7.6 | 7.9 | 8.7 | 6.0 |